UBS ASSET MANAGEMENT AMERICAS INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$16,659,371,000
+27.2%
244,631
-40.3%
0.01%
+28.6%
Q2 2022$13,097,038,000
+394.4%
409,923
+436.0%
0.01%
+600.0%
Q1 2022$2,649,059,000
+20.5%
76,474
+1.8%
0.00%0.0%
Q4 2021$2,198,909,000
+14.9%
75,1250.0%0.00%0.0%
Q3 2021$1,914,184,000
-26.4%
75,125
+1.1%
0.00%0.0%
Q2 2021$2,600,970,000
-30.5%
74,271
-19.2%
0.00%
-50.0%
Q1 2021$3,744,192,000
-3.4%
91,882
+2.6%
0.00%0.0%
Q4 2020$3,876,765,000
-5.3%
89,512
+20.6%
0.00%0.0%
Q3 2020$4,092,437,000
-10.3%
74,219
+2.7%
0.00%
-33.3%
Q2 2020$4,561,838,000
+24.1%
72,261
+0.4%
0.00%0.0%
Q1 2020$3,677,408,000
-30.1%
71,979
+8.8%
0.00%0.0%
Q4 2019$5,260,092,000
+76.7%
66,173
+7.9%
0.00%
+50.0%
Q3 2019$2,976,459,000
+14.5%
61,345
+24.1%
0.00%0.0%
Q2 2019$2,600,334,000
+28.9%
49,436
+29.7%
0.00%
+100.0%
Q1 2019$2,017,850,000
+23.9%
38,123
-3.9%
0.00%0.0%
Q4 2018$1,628,043,000
+35.4%
39,660
+25.3%
0.00%0.0%
Q3 2018$1,202,548,000
-14.0%
31,646
+2.3%
0.00%0.0%
Q2 2018$1,398,533,000
-3.1%
30,941
+3.5%
0.00%0.0%
Q1 2018$1,443,783,000
+52.8%
29,892
+24.5%
0.00%0.0%
Q4 2017$944,833,000
+305.7%
24,011
+220.1%
0.00%
Q3 2017$232,875,000
+13.5%
7,5000.0%0.00%
Q2 2017$205,125,000
-65.6%
7,500
-53.7%
0.00%
-100.0%
Q1 2017$596,675,00016,1920.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders